Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA

INTRODUCTION: Patients with rheumatoid arthritis (RA) may respond to treatments differently based on their underlying serology and biomarker status, but real-world data comparing treatment responses to abatacept versus other non-TNFi biologic or targeted-synthetic DMARDs by anti-citrullinated protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., Connolly, Sean E., Wittstock, Keith, Zhuo, Joe, Kelly, Sheila, Lehman, Thomas, Shan, Ying, Rebello, Sabrina, Guo, Lin, Khaychuk, Vadim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964884/
https://www.ncbi.nlm.nih.gov/pubmed/34940957
http://dx.doi.org/10.1007/s40744-021-00401-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964884/
https://www.ncbi.nlm.nih.gov/pubmed/34940957
http://dx.doi.org/10.1007/s40744-021-00401-0

Ejemplares similares